February 27, 2020 / 12:38 PM / a month ago

BRIEF-Adaptimmune Reports Qtrly Loss Per Share $0.05

Feb 27 (Reuters) - Adaptimmune Therapeutics PLC:

* ADAPTIMMUNE REPORTS FOURTH QUARTER / FULL YEAR 2019 FINANCIAL RESULTS AND BUSINESS UPDATE

* ADAPTIMMUNE THERAPEUTICS PLC - GOAL TO LAUNCH ADP-A2M4 FOR SARCOMA IN 2022

* ADAPTIMMUNE THERAPEUTICS PLC QTRLY REVENUE $0.7 MILLION COMPARED TO $1.5 MILLION

* ADAPTIMMUNE THERAPEUTICS PLC QTRLY LOSS PER SHARE $0.05 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below